Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)

Ginkgo Bioworks Holdings (DNA) posted Change in Working Capital of $4.7 million for Q2 2023, down 44.5% on a QoQ basis from $8.5 million in Q1 2023, and up 76.52% year-over-year from $2.7 million in Q2 2022.

Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings' Change in Working Capital history runs 2 years deep, the most recent figure standing at $4.7 million for Q2 2023.

  • Quarterly Change in Working Capital rose 76.52% year-over-year to $4.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18.6 million (changed N/A YoY) and the FY2022 annual result came in at $10.8 million, changed N/A from the prior year.
  • Change in Working Capital was $4.7 million for Q2 2023 at Ginkgo Bioworks Holdings, down from $8.5 million in the prior quarter.
  • Across five years, Change in Working Capital topped out at $8.5 million in Q1 2023 and bottomed at $2.7 million in Q1 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 4.73 Mn
Jun 30, 2023 4.73 Mn
Mar 31, 2023 8.52 Mn
Mar 31, 2023 8.52 Mn
Jun 30, 2022 2.68 Mn
Jun 30, 2022 2.68 Mn
Mar 31, 2022 2.65 Mn
Mar 31, 2022 2.65 Mn